Incidence of non-alcoholic fatty liver disease in antiretroviral therapy-naïve people with human immunodeficiency virus who start DTG/ABC/3TC compared to BIC/FTC/TAF at 48-week follow-up
There is a high incidence of NAFLD in PLWH who start a second generation INSTI at 48 weeks; baseline overweight, low HDL-cholesterol and FIB-4 >1.3 at 48 weeks of treatment were independent risk factors for NAFLD development.
Authors
- Stefan Mauss (ORCID: https://orcid.org/0009-0007-2657-3738)
- Ana Luz Cano-Díaz (ORCID: https://orcid.org/0000-0001-9659-746X)
- José Antonio Mata‐Marín (ORCID: https://orcid.org/0000-0003-1329-7811)
- Jesús Enrique Gaytán Martínez
- S. González
- Gloria Elizabeth Salinas Velázquez
Institutions
- Mexican Social Security Institute (MX)
- Centro Médico Nacional La Raza (MX)
- Center for HIV and Hepatogastroenterology (DE)
Publication Details
- Journal
- International Journal of STD & AIDS
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1177/09564624241287886
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39